| Immunotherapies Pharmaceuticals_and_biotechnology > Critical therapies > Immunotherapies |  |
Discovering, developing and commercializing new therapeutic agents.
Engaged in the research, development and commercialization of unique antibody-based immunotherapeutics, initially for the treatment of cancer.
As a producer of plasma derived products, the company provides therapies to treat hemophilia, immune disorders, and shock.
Involved in the development of immunotherapy products for the possible treatment and cure of cancers, autoimmune diseases, infectious diseases and allergy-related conditions.
Development of pharmaceutical and biotechnological treatments.
PEGASYS (Peginterferon alfa-2a) from Hoffmann-La Roche Inc. Provides therapy, dosing and safety information for US patients and health professionals
Research and development in the area of immunology to promote the prevention and treatment of infectious disease and cancer.
Pharmaceutical company engaged in the development and commercialization of innovative therapeutic products that work with the body's healing mechanisms.
Mercodia develops, manufactures and markets diagnostic kits based on immunological reactions (ELISA and RIA,) for the human health care sector.
International pharmaceutical company involved in the development of therapeutics by changing macrophage-mediated immune responses to treat diseases.
Specialized in prescription medicine for gynaecology, psychiatry, immunology and athero-thrombosis. Headquartered in Netherlands.
Provider of biotechnological products to prevent and treat severe immune-mediated human diseases.
Biopharmaceutical company focused on the discovery and development of small molecule, biotherapeutic (antibodies and proteins) and predictive medicine products.
A biopharmaceutical manufacturer of products to enhance human and animal immune systems using its Transcutaneous Immuno Modulation (TIM) technology for immuno prevention and immuno therapy.
| Nb of links = 14 |